Protagenic Therapeutics, Inc.\new Foreign Currency Transaction Gain (Loss), before Tax
Protagenic Therapeutics, Inc.\new (PTIX) reported Foreign Currency Transaction Gain (Loss), before Tax of -$6.63 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-04-02.
Discontinued › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2018-04-02
- Protagenic Therapeutics, Inc.\new foreign currency transaction gain (loss), before tax for the quarter ending 2016-12-31 was $17.00, a 99.98% decline year-over-year.
- Protagenic Therapeutics, Inc.\new foreign currency transaction gain (loss), before tax for the quarter ending 2016-09-30 was -$43.00.
- Protagenic Therapeutics, Inc.\new foreign currency transaction gain (loss), before tax for the quarter ending 2016-06-30 was $543.00.
- Protagenic Therapeutics, Inc.\new foreign currency transaction gain (loss), before tax for the quarter ending 2016-03-31 was -$7.14K, a 158.88% decline year-over-year.
- Protagenic Therapeutics, Inc.\new foreign currency transaction gain (loss), before tax for fiscal 2016 was -$6.63K, a 150.62% decline from fiscal 2015.
- Protagenic Therapeutics, Inc.\new foreign currency transaction gain (loss), before tax for fiscal 2015 was $13.09K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2016-12-31 | $17.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$26.00 derived: sum of 2 quarters · filed 2018-04-02 | $517.00 derived: sum of 3 quarters · filed 2018-04-02 | -$6.63K 10-K · filed 2018-04-02 |
| 2016-09-30 | -$43.00 10-Q · filed 2017-11-13 | $500.00 derived: sum of 2 quarters · filed 2017-11-13 | -$6.64K 10-Q · filed 2017-11-13 | $81.11K derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | $543.00 10-Q · filed 2017-08-08 | -$6.60K 10-Q · filed 2017-08-08 | $81.15K derived: sum of 3 quarters · filed 2017-08-08 | $2.52K derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | -$7.14K 10-Q · filed 2017-05-15 | $80.61K derived: sum of 2 quarters · filed 2017-05-15 | $1.97K derived: sum of 3 quarters · filed 2017-05-15 | -$6.18K derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $87.75K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-05-08 | $9.12K derived: sum of 2 quarters · filed 2017-05-08 | $959.00 derived: sum of 3 quarters · filed 2017-05-08 | $13.09K 10-K/A · filed 2017-05-08 |
| 2015-09-30 | -$78.64K 10-Q · filed 2016-11-17 | -$86.79K derived: sum of 2 quarters · filed 2016-11-17 | -$74.66K 10-Q · filed 2016-11-17 | |
| 2015-06-30 | -$8.16K 10-Q · filed 2016-08-15 | $3.97K 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | $12.13K 10-Q · filed 2016-07-25 | |||
| 2014-12-31 | -$10.43K 8-K/A · filed 2016-07-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |